Abstract
Somatostatin is an important physiological regulator of neuroendocrine function across multiple biological systems, including the brain and the gastrointestinal tract. In the pituitary gland, somatostatin regulates the secretion of hormones such as growth hormone and thyroid-stimulating hormone in healthy and pathological states. The short half-life of somatostatin makes it unsuitable for clinical use in chronic diseases, which led to the development of long-acting somatostatin analogs for the treatment of acromegaly and thyroid-stimulating hormone-secreting adenomas, which were administered by intermittent injection twice or three times a day. More recently, depot versions have been developed that permit dosing once every month. This review assesses the efficacy of somatostatin analogs in the treatment of pituitary adenomas, including acromegaly, thyroid-stimulating hormone-secreting tumors, non-functioning adenomas, and Cushing’s disease.
Similar content being viewed by others
References
Ezzat, S., Asa, S. L., Couldwell, W. T., et al. (2004). Cancer 101, 613–619.
Arafah, B. M. and Nasrallah, M. P. (2001). Endocr. Relat Cancer. 8, 287–305.
Scheithauer, B. W., Kurtkaya-Yapicier, O., Kovacs, K. T., Young, W. F. Jr., and Lloyd, R. V. (2005). Neurosurgery 56, 1066–1074.
Lamberts, S. W., van der Lely, A. J., de Herder, W. W., and Hofland, L. J. (1996). N. Engl. J. Med. 334, 246–254.
Brazeau, P. and Guillemin, R. (1974). N. Engl. J. Med. 290, 963–964.
Reichlin, S. (1987). J. Lab Clin. Med. 109, 320–326.
Krantic, S., Goddard, I., Saveanu, A., et al. (2004). Eur. J. Endocrinol. 151, 643–655.
Wynick, D. and Bloom, S. R. (1991). J. Clin. Endocrinol. Metab. 73, 1–3.
Lahlou, H., Guillermet, J., Hortala, M., et al. (2004). Ann. NY Acad. Sci. 1014, 121–131.
Epelbaum, J., Agid, F., Agid, Y., et al. (1989). Horm. Res. 31, 45–50.
Schally, A. V. (1988). Cancer Res. 48, 6977–6985.
Cheung, N. W. and Boyages, S. C. (1995). Endocrinology 136, 4174–4181.
Yoshitomi, H., Fujii, Y., Miyazaki, M., Nakajima, N., Inagaki, N., and Seino, S. (1997). Am. J. Physiol. 272, E769-E774.
Hofland, L. J. and Lamberts, S. W. (2003). Endocr. Rev. 24, 28–47.
Patel, Y. C. (1997). J. Endocrinol. Invest. 20, 348–367.
Reubi, J. C. (2003). Endocr. Rev. 24, 389–427.
Reubi, J. C., Kvols, L., Krenning, E., and Lamberts, S. W. (1990). Metabolism 39, 78–81.
Saveanu, A., Gunz, G., Dufour, H., Enjalbert, A., Culler, M. D., and Jaquet, P. (2003). J. Endocrinol. Invest. 26, 4–7.
Shimon, I., Taylor, J. E., Dong, J. Z., et al. (1997). J. Clin. Invest. 99, 789–798.
Greenman, Y. and Melmed, S. (1994). J. Clin. Endocrinol. Metab. 78, 398–403.
Greenman, Y. and Melmed, S. (1994). J. Clin. Endocrinol. Metab. 79, 724–729.
Sharma, K., Patel, Y. C., and Srikant, C. B. (1999). Mol. Endocrinol. 13, 82–90.
Teijeiro, R., Rios, R., Costoya, J. A., et al. (2002). Cell Physiol. Biochem. 12, 31–38.
Lattuada, D., Casnici, C., Venuto, A., and Marelli, O. (2002). J. Neuroimmunol. 133, 211–216.
Schonbrunn, A., Gu, Y. Z., Dournard, P., Beaudet, A., Tannenbaum, G. S., and Brown, P. J. (1996). Metabolism 45, 8–11.
Vale, W., Rivier, J., Ling, N., and Brown, M. (1978). Metabolism 27, 1391–1401.
Bauer, W., Briner, U., Doepfner, W., et al. (1982). Life Sci. 31, 1133–1140.
Flogstad, A. K., Halse, J., Haldorsen, T., et al. (1995). J. Clin. Endocrinol. Metab. 80, 3601–3607.
Stewart, P. M., Kane, K. F., Stewart, S. E., Lancranjan, I., and Sheppard, M. C. (1995). J. Clin. Endocrinol. Metab. 80, 3267–3272.
Grass, P., Marbach, P., Bruns, C., and Lancranjan, I. (1996). Metabolism 45, 27–30.
Turner, H. E., Thornton-Jones, V. A., and Wass, J. A. (2004). Clin. Endocrinol. (Oxf.) 61, 224–231.
Morange, I., De Boisvilliers, F., Chanson, P., et al. (1994). J. Clin. Endocrinol. Metab. 79, 145–151.
Soule, S., Conway, G., Hatfield, A., and Jacobs, H. (1996). J. Clin. Endocrinol. Metab. 81, 4502–4503.
Giusti, M., Ciccarelli, E., Dallabonzana, D., et al. (1997). Eur. J. Clin. Invest. 27, 277–284.
Ciccarelli, A., Daly, A., and Beckers, A. (2004). Treat. Endocrinol. 3, 77–81.
Caron, P., Beckers, A., Cullen, D. R., et al. (2002). J. Clin. Endocrinol. Metab. 87, 99–104.
Caron, P., Bex, M., Cullen, D. R., et al. (2004). Clin. Endocrinol. (Oxf.) 60, 734–740.
Krenning, E. P., Kwekkeboom, D. J., Reubi, J. C., et al. (1992). Metabolism 41, 83–86.
van der Lely, A. J., Beckers, A., Daly, A., Lamberts, S. W., and Clemmons, D. (2005). In: Acromegaly: pathology, diagnosis and treatment. Taylor and Francis: New York.
Stevenaert, A. and Beckers, A. (1996). Metabolism 45, 72–74.
Sheppard, M. C. (2003). Clin. Endocrinol. (Oxf.) 58, 387–399.
Newman, C. B., Melmed, S., George, A., et al. (1998). J. Clin. Endocrinol. Metab. 83, 3034–3040.
Petrossians, P., Borges-Martins, L., Espinoza, C., et al. (2005). Eur. J. Endocrinol. 152, 61–66.
Lamberts, S. W., Uitterlinden, P., Verschoor, L., van Dongen, K. J., and Del Pozo, E. (1985). N. Engl. J. Med. 313, 1576–1580.
Lamberts, S. W., Oosterom, R., Neufeld, M., and Del Pozo, E. (1985). J. Clin. Endocrinol. Metab. 60, 1161–1165.
Vance, M. L. and Harris, A. G. (1991). Arch. Intern. Med. 151, 1573–1578.
Sassolas, G., Harris, A. G., and James-Deidier, A. (1990). J. Clin. Endocrinol. Metab. 71, 391–397.
Ezzat, S., Snyder, P. J., Young, W. F., et al. (1992). Ann. Intern. Med. 117, 711–718.
Melmed, S., Casanueva, F. F., Cavagnini, F., et al. (2002). J. Clin. Endocrinol. Metab. 87, 4054–4058.
Newman, C. B., Melmed, S., Snyder, P. J., et al. (1995). J. Clin. Endocrinol. Metab. 80, 2768–2775.
Freda, P. U. (2002). J. Clin. Endocrinol. Metab. 87, 3013–3018.
Melmed, S., Sternberg, R., Cook, D., et al. (2005). J. Clin. Endocrinol. Metab. 10.1210/jc.2004-2466.
Freda, P. U., Katznelson, L., van der Lely, A. J., Reyes, C. M., Zhao, S., and Rabinowitz, D. (2005). J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-0260.
Bevan, J. S. (2005). J. Clin. Endocrinol. Metab. 90, 1856–1863.
Levy, M. J., Bejon, P., Barakat, M., Goadsby, P. J., and Meeran, K. (2003). Headache 43, 794–797.
Donangelo, I., Rodacki, M., Peixoto, M. C., Vaisman, M., Caldas, N. R., and Gadelha, M. R. (2004). Endocr. Pract. 10, 107–111.
May, A., Lederbogen, S., and Diener, H. C. (1994). Cephalalgia 14, 303–304.
Musolino, N. R., Marino, Junior R., and Bronstein, M. D. (1990). Clin. J. Pain 6, 243–245.
Pascual, J., Freijanes, J., Berciano, J., and Pesquera, C. (1991). Pain 47, 341–344.
Popovic, V., Paunovic, V. R., Micic, D., et al. (1988). Horm. Metab. Res. 20, 250–251.
Schmidt, K., Althoff, P. H., Harris, A. G., Prestele, H., Schumm-Draeger, P. M., and Usadel, K. H. (1993). Pain 53, 223–227.
Colao, A., Cuocolo, A., Marzullo, P., et al. (1999). J. Clin. Endocrinol. Metab. 84, 1518–1523.
Nishiki, M., Murakami, Y., Sohmiya, M., et al. (1997). Endocr. J. 44, 655–660.
Bihan, H., Espinosa, C., Valdes-Socin, H., et al. (2004). J. Clin. Endocrinol. Metab. 89, 5308–5313.
Colao, A., Marzullo, P., Ferone, D., et al. (2000). J. Clin. Endocrinol. Metab. 85, 3132–3140.
Colao, A., Marzullo, P., Cuocolo, A., et al. (2003). Clin. Endocrinol. (Oxf.) 58, 169–176.
Biermasz, N. R., Pereira, A. M., Smit, J. W., Romijn, J. A., and Roelfsema, F. (2005). J. Clin. Endocrinol. Metab. 90, 2731–2739.
Biermasz, N. R., van Thiel, S. W., Pereira, A. M., et al. (2004). J. Clin. Endocrinol. Metab. 89, 5369–5376.
Stevenaert, A., Harris, A. G., Kovacs, K., and Beckers, A. (1992). Metabolism 41, 51–58.
Ezzat, S., Kontogeorgos, G., Redelmeier, D. A., Horvath, E., Harris, A. G., and Kovacs, K. (1995). Eur. J. Endocrinol. 133, 686–690.
Ezzat, S., Horvath, E., Harris, A. G., and Kovacs, K. (1994). J. Clin. Endocrinol. Metab. 79, 113–118.
Losa, M., Ciccarelli, E., Mortini, P., et al. (2001). J. Clin. Endocrinol. Metab. 86, 5194–5200.
Barakat, S. and Melmed, S. (1989). Arch. Intern. Med. 149, 1443–1445.
Arosio, M., Macchelli, S., Rossi, C. M., Casati, G., Biella, O., and Faglia, G. (1995). Eur. J. Endocrinol. 133, 430–439.
Lundin, P., Eden Engstrom B., Karlsson, F. A., and Burman, P. (1997). AJNR Am. J. Neuroradiol. 18, 765–772.
Beck-Peccoz, P. and Persani, L. (2002). Pituitary 5, 83–88.
Beck-Peccoz, P., Brucker-Davis, F., Persani, L., Smallridge, R. C., and Weintraub, B. D. (1996). Endocr. Rev. 17, 610–638.
Siler, T. M., Yen, S. C., Vale, W., and Guillemin, R. (1974). J. Clin. Endocrinol. Metab. 38, 742–745.
Caron, P., Arlot, S., Bauters, C., et al. (2001). J. Clin. Endocrinol. Metab. 86, 2849–2853.
Chanson, P., Weintraub, B. D., and Harris, A. G. (1993). Ann. Intern. Med. 119, 236–240.
Warnet, A., Lajeunie, E., Gelbert, F., et al. (1991). Acta Endocrinol. (Copenh.) 124, 487–491.
Kuhn, J. M., Arlot, S., Lefebvre, H., et al. (2000). J. Clin. Endocrinol. Metab. 85, 1487–1491.
Socin, H. V., Chanson, P., Delemer, B., et al. (2003). Eur. J. Endocrinol. 148, 433–442.
Snyder, P. J. (1993). Endocrinol. Metab. Clin. North Am. 22, 163–175.
Klibanski, A., Alexander, J. M., Bikkal, H. A., Hsu, D. W., Swearingen, B., and Zervas, N. T. (1991). J. Clin. Endocrinol. Metab. 73, 1248–1255.
Florio, T., Thellung, S., Arena, S., et al. (1999). Eur. J. Endocrinol. 141, 396–408.
Broson-Chazot, F., Houzard, C., Ajzenberg, C., et al. (1997). Clin. Endocrinol. (Oxf.) 47, 589–598.
Warnet, A., Harris, A. G., Renard, E., Martin, D., James-Deidier, A., and Chaumet-Riffaud, P. (1997). Neurosurgery 41, 786–795.
Shomali, M. E. and Katznelson, L. (2002). Pituitary 5, 89–98.
Labeur, M., Arzt, E., Stalla, G. K., and Paez-Pereda, M. (2004). Curr. Drug Targets. Immune. Endocr. Metabol. Disord. 4, 335–342.
Lamberts, S. W., Uitterlinden, P., and Klijn, J. M. (1989). Acta Endocrinol. (Copenh.) 120, 760–766.
Stalla, G. K., Brockmeier, S. J., Renner, U., et al. (1994). Eur. J. Endocrinol. 130, 125–131.
Woodhouse, N. J., Dagogo-Jack, S., Ahmed, M., and Judzewitsch, R. (1993). Am. J. Med. 95, 305–308.
Ambrosi, B., Bochicchio, D., Fadin, C., Colombo, P., and Faglia, G. (1990). J. Endocrinol. Invest. 13, 257–261.
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., and Weckbecker, G. (2002). Eur. J. Endocrinol. 146, 707–716.
Hofland, L. J., van der, Hoek J., Feelders, R., et al. (2005). Eur. J. Endocrinol. 152, 645–654.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tichomirowa, M.A., Daly, A.F. & Beckers, A. Treatment of pituitary tumors. Endocr 28, 93–99 (2005). https://doi.org/10.1385/ENDO:28:1:093
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:28:1:093